What's Happening?
The Center for Medicare and Medicaid Innovation (CMMI) has introduced the Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model, a 10-year initiative aimed at enhancing chronic condition management through technology and artificial intelligence.
This program, announced in December, seeks to provide stable payments for technology used in treating conditions such as diabetes, hypertension, and depression. The ACCESS Model aligns with the Centers for Medicare and Medicaid Services' goal of integrating all traditional Medicare beneficiaries into accountable care relationships by 2030. It introduces a new category of Medicare Part B providers, known as ACCESS organizations, which will receive payments based on outcomes rather than specific activities. The model is designed to break down barriers to digital health access for Medicare patients, offering a 'Medicare app store' for beneficiaries to choose suitable digital health programs.
Why It's Important?
The ACCESS Model represents a significant shift in how chronic care is managed and reimbursed, moving away from traditional fee-for-service models to outcome-based payments. This approach could lead to more efficient use of resources and improved patient outcomes by leveraging technology and AI. The model's focus on scalable solutions could address the primary care shortage by enabling broader access to care management. However, the lower-than-expected reimbursement rates pose challenges for some digital health companies, potentially impacting their participation. The initiative's success could influence broader adoption of similar models by commercial payers and employers, promoting value-based care across the healthcare system.
What's Next?
The ACCESS Model is set to begin on July 5, 2026, and will run through June 30, 2036. As the program rolls out, participating companies will need to collaborate closely with primary care providers to ensure effective integration and avoid care fragmentation. The model's success will depend on its ability to demonstrate improved outcomes and cost savings, which could encourage further adoption by commercial payers. The initiative also serves as a test for AI-enabled care at scale, with the potential to reshape chronic care management if successful.
